Prostate Cancer

Prostate Brachytherapy On the Decline

Prostate Brachytherapy On the Decline

By

Use of this treatment for localized prostate cancer has been decreasing since 2002, perhaps due to increasing use of radical prostatectomy.

Adjuvant Radiotherapy Cuts PCa Death Risk in Higher Risk Patients

Adjuvant Radiotherapy Cuts PCa Death Risk in Higher Risk Patients

By

Researchers observe benefit in prostate cancer patients with 2 or more adverse pathologic features.

Robotic Prostate Surgery Implicated in PLND Decline

Robotic Prostate Surgery Implicated in PLND Decline

By

Pelvic lymph node dissection in high-risk patients is 2.5 times more likely in those undergoing open rather than robotic-assisted surgery.

Preop MRI Benefits Some Prostate Cancer Patients

Preop MRI Benefits Some Prostate Cancer Patients

By

Men with non-palpable tumors had a 46% lower risk of positive surgical margins.

Prostate Cancer Active Surveillance Safe Long Term

Prostate Cancer Active Surveillance Safe Long Term

By

Patients are more than 9 times more likely to die from causes other than PCa, a new study shows.

Blood Type O Predicts Lower Prostate Cancer Recurrence Risk

Blood Type O Predicts Lower Prostate Cancer Recurrence Risk

By

It is associated with a 34.7% decrease in biochemical recurrence after radical prostatectomy versus patients with blood type A.

Adding ADT to Radiotherapy Improves Prostate Cancer Outcomes

Adding ADT to Radiotherapy Improves Prostate Cancer Outcomes

By

The combined treatment was associated with a reduced risk of biochemical and clinical progression compared with radiotherapy alone.

Osteoporosis May Be Present Before Prostate Cancer ADT

Osteoporosis May Be Present Before Prostate Cancer ADT

By

Danish study reveals a 10% prevalence of osteoporosis among men due to start androgen-deprivation therapy.

Tadalafil Not Helpful for ED in PCa Post-Radiotherapy

Tadalafil Not Helpful for ED in PCa Post-Radiotherapy

Drug no better than placebo in preventing erectile dysfunction after radiotherapy for prostate cancer.

PSA Nadir in ADT Recipients: The Lower, The Better

PSA Nadir in ADT Recipients: The Lower, The Better

By

The nadir should be below 0.01 ng/mL because even levels of 0.01 to 0.2 ng/mL predict an increased risk of adverse outcomes.

Use Transperineal Biopsy More, Researchers Say

Use Transperineal Biopsy More, Researchers Say

By

Men who need a prostate biopsy should be offered TP as a possible alternative to TRUS-guided biopsy.

Nutrition Advice Challenged — Again

Nutrition Advice Challenged — Again

By

Human beings are unique in the animal kingdom when it comes to nutrition.

Omega-3s and Prostate Cancer: What to Advise Patients

Omega-3s and Prostate Cancer: What to Advise Patients

By

Some researchers are not convinced that high blood levels of omega-3 fatty acids are associated with an increased PCa risk.

Radiotherapy After Prostate Cancer Surgery Improves Outcomes

Radiotherapy After Prostate Cancer Surgery Improves Outcomes

By

It is associated with a decreased risk of disease progression compared with a wait-and-see approach.

MRI Improves Detection of Higher Risk Prostate Cancer

MRI Improves Detection of Higher Risk Prostate Cancer

By

Magnetic resonance imaging can identify men more likely to harbor intermediate- and high-risk tumors.

CTCs Predict Survival in Men with Metastatic CRPC

CTCs Predict Survival in Men with Metastatic CRPC

By

Higher circulating tumor cell counts are associated with an increased risk of death.

Primary ADT Not Beneficial in Most Cases of Early Prostate Cancer

Primary ADT Not Beneficial in Most Cases of Early Prostate Cancer

By

The treatment, however, is associated with a decreased risk of all-cause mortality in men at high risk of disease progression.

PSA Screening Declining, Especially Among Urologists

PSA Screening Declining, Especially Among Urologists

By

Trend follows the 2012 release of a U.S. Preventive Services Task Force recommendation against such testing.

Newer Radiotherapy Is Less Costly, More Toxic

Newer Radiotherapy Is Less Costly, More Toxic

By

The cost of stereotactic body radiation therapy is about one-third less than intensity-modulated radiation therapy, study finds.

Bone Turnover Biomarkers Predict CRPC Course

Bone Turnover Biomarkers Predict CRPC Course

By

High levels are associated with worse survival, study finds.

Drug Makers Seek New Indication for Prostate Cancer Drug

Drug Makers Seek New Indication for Prostate Cancer Drug

By

Astellus Pharma and Medivation ask the FDA to approve enzalutamide as a treatment for advanced prostate cancer in chemotherapy-naïve men.

Study Supports Surgery for High-Risk Prostate Cancer

Study Supports Surgery for High-Risk Prostate Cancer

By

Radical prostatectomy is associated with excellent long-term overall and cancer-specific survival.

PCa Patients Prefer Specific Info from Physicians

PCa Patients Prefer Specific Info from Physicians

Patients cite treatment description by the treating physician as the most helpful source.

Cholesterol Compound Could Be Target in Prostate Cancer Therapy

Cholesterol Compound Could Be Target in Prostate Cancer Therapy

By

Researchers found an unexpected, aberrant accumulation of esterified cholesterol in human PCa tissue.

Sidestepping Sepsis via TP Biopsy: Interview with Jeremy Grummet, MBBS, MS, FRACS

Sidestepping Sepsis via TP Biopsy: Interview with Jeremy Grummet, MBBS, MS, FRACS

By

Rising readmission rates of subsequent sepsis have given urologic surgeon Jeremy Grummet, MBBS, MS, FRACS, pause.

Prostate Cancer Outcomes Worse with Watchful Waiting

Prostate Cancer Outcomes Worse with Watchful Waiting

By

At 18 years of follow-up, patients who underwent radical surgery had a decreased risk of cancer-related and all-cause mortality.

Bisphenol A May Boost Prostate Cancer Risk

Bisphenol A May Boost Prostate Cancer Risk

By

Elevated urinary levels of the organic compound were found in men with prostate cancer than in those without it.

Should urologists increase use of transperineal prostate biopsies?

By

Researchers have proposed that TP prostate biopsies be offered an option to all men.

Prostate Cancer Control Better with Robot-Assisted Surgery

Prostate Cancer Control Better with Robot-Assisted Surgery

By

It is associated with fewer positive surgical margins and reduced need for additional treatment.

CDC: Cancer Prevention Services Below Target Goals

CDC: Cancer Prevention Services Below Target Goals

Increasing health insurance coverage and access to usual source of care necessary to meet targets.

Sign Up for Free e-newsletters